LifeStance Health Reports Strong Q2 2025 Results, Raises Full-Year Guidance

Reuters
2025/08/07
<a href="https://laohu8.com/S/LFST">LifeStance Health</a> Reports Strong <a href="https://laohu8.com/S/QTWO">Q2</a> 2025 Results, Raises Full-Year Guidance

LifeStance Health Group Inc. recently held their second quarter 2025 earnings conference call, where the management team, including CEO Dave Bourdon, announced strong financial results. The company achieved double-digit organic revenue growth and 10% adjusted EBITDA margins, prompting an increase in full-year guidance for adjusted EBITDA. LifeStance also reported a record free cash flow of $57 million, reflecting the resilience and differentiation of their patient care model, which offers both in-person and virtual care. The full speech/interview is available on their Investor Relations website. For more details, visit investor.lifestance.com.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LifeStance Health Group Inc. published the original content used to generate this news brief on August 07, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10